Literature DB >> 21704184

Getting physical in drug discovery II: the impact of chromatographic hydrophobicity measurements and aromaticity.

Robert J Young1, Darren V S Green, Christopher N Luscombe, Alan P Hill.   

Abstract

Here, we review the performance of chromatographic hydrophobicity measurements in a data set of 100,000 GlaxoSmithKline compounds, demonstrating the advantages of the method over octanol-water partitioning and highlighting new insights for drug discovery. The value of chromatographic measurements, versus other hydrophobicity estimates, was supported by improved relationships with solubility, permeation, cytochrome P450s, intrinsic clearance, hERG binding and promiscuity. We also observed marked differentiation of the relative influence of intrinsic and effective hydrophobicity. The summing of hydrophobicity values plus aromatic ring count [logD(pH7.4) (or logP)+#Ar], indicated a wide relevance for simplistic 'property forecast indices' in developability assays, clearly enhanced by chromatographic values; therefore establishing new foundations for enriching property-based drug design.
Copyright © 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21704184     DOI: 10.1016/j.drudis.2011.06.001

Source DB:  PubMed          Journal:  Drug Discov Today        ISSN: 1359-6446            Impact factor:   7.851


  52 in total

Review 1.  Finding the sweet spot: the role of nature and nurture in medicinal chemistry.

Authors:  Michael M Hann; György M Keserü
Journal:  Nat Rev Drug Discov       Date:  2012-04-30       Impact factor: 84.694

2.  Calculating Partition Coefficients of Small Molecules in Octanol/Water and Cyclohexane/Water.

Authors:  Caitlin C Bannan; Gaetano Calabró; Daisy Y Kyu; David L Mobley
Journal:  J Chem Theory Comput       Date:  2016-08-01       Impact factor: 6.006

3.  Identification, preclinical profile, and clinical proof of concept of an orally bioavailable pro-drug of miridesap.

Authors:  Duncan Richards; Mark Bamford; Lia Liefaard; Nazneen Haque; Gareth Lewis; Jim Storey; Disala Fernando; Subramanya Kumar; Douglas Thompson; Duncan S Holmes
Journal:  Br J Pharmacol       Date:  2020-02-11       Impact factor: 8.739

4.  Structure Activity Relationships of αv Integrin Antagonists for Pulmonary Fibrosis by Variation in Aryl Substituents.

Authors:  James Adams; Edward C Anderson; Emma E Blackham; Yin Wa Ryan Chiu; Thomas Clarke; Natasha Eccles; Luke A Gill; Joshua J Haye; Harvey T Haywood; Christian R Hoenig; Marius Kausas; Joelle Le; Hannah L Russell; Christopher Smedley; William J Tipping; Tom Tongue; Charlotte C Wood; Jason Yeung; James E Rowedder; M Jonathan Fray; Thomas McInally; Simon J F Macdonald
Journal:  ACS Med Chem Lett       Date:  2014-09-19       Impact factor: 4.345

5.  Testing tuberculosis drug efficacy in a zebrafish high-throughput translational medicine screen.

Authors:  Anita Ordas; Robert-Jan Raterink; Fraser Cunningham; Hans J Jansen; Malgorzata I Wiweger; Susanne Jong-Raadsen; Sabine Bos; Robert H Bates; David Barros; Annemarie H Meijer; Rob J Vreeken; Lluís Ballell-Pages; Ron P Dirks; Thomas Hankemeier; Herman P Spaink
Journal:  Antimicrob Agents Chemother       Date:  2014-11-10       Impact factor: 5.191

6.  Molecular Property Design: Does Everyone Get It?

Authors:  Paul D Leeson; Robert J Young
Journal:  ACS Med Chem Lett       Date:  2015-05-27       Impact factor: 4.345

7.  Binding site characterization - similarity, promiscuity, and druggability.

Authors:  Christiane Ehrt; Tobias Brinkjost; Oliver Koch
Journal:  Medchemcomm       Date:  2019-06-06       Impact factor: 3.597

Review 8.  The role of ligand efficiency metrics in drug discovery.

Authors:  Andrew L Hopkins; György M Keserü; Paul D Leeson; David C Rees; Charles H Reynolds
Journal:  Nat Rev Drug Discov       Date:  2014-02       Impact factor: 84.694

9.  Identification via a Parallel Hit Progression Strategy of Improved Small Molecule Inhibitors of the Malaria Purine Uptake Transporter that Inhibit Plasmodium falciparum Parasite Proliferation.

Authors:  Yvett Sosa; Roman Deniskin; I J Frame; Matthew S Steiginga; Deepak Bandyopadhyay; Todd L Graybill; Lorena A Kallal; Michael T Ouellette; Andrew J Pope; Katherine L Widdowson; Robert J Young; Myles H Akabas
Journal:  ACS Infect Dis       Date:  2019-08-14       Impact factor: 5.084

10.  Prediction of Drug Penetration in Tuberculosis Lesions.

Authors:  Jansy P Sarathy; Fabio Zuccotto; Ho Hsinpin; Lars Sandberg; Laura E Via; Gwendolyn A Marriner; Thierry Masquelin; Paul Wyatt; Peter Ray; Véronique Dartois
Journal:  ACS Infect Dis       Date:  2016-07-06       Impact factor: 5.084

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.